[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global Liquid Biopsy in Cancer Diagnostics Industry Research Report, Competitive Landscape, Market Size, Regional Status and Prospect

November 2023 | 120 pages | ID: G536518D82BFEN
Maia Research

US$ 3,250.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
The report combines extensive quantitative analysis and exhaustive qualitative analysis, ranges from a macro overview of the total market size, industry chain, and market dynamics to micro details of segment markets by type, application and region, and, as a result, provides a holistic view of, as well as a deep insight into the Liquid Biopsy in Cancer Diagnostics market covering all its essential aspects.

For the competitive landscape, the report also introduces players in the industry from the perspective of the market share, concentration ratio, etc., and describes the leading companies in detail, with which the readers can get a better idea of their competitors and acquire an in-depth understanding of the competitive situation. Further, mergers & acquisitions, emerging market trends, the impact of COVID-19, and regional conflicts will all be considered.

In a nutshell, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the market in any manner.

Key players in the global Liquid Biopsy in Cancer Diagnostics market are covered in Chapter 9:

Bio-Techne
Neogenomics Laboratories
Agilent Technologies Inc
Personal Gemone Diagnostics Inc
Guardant Health
Agena Bioscience Inc
Sysmex Corporation
Thermo Fisher Scientific Inc
Exact Sciences Corporation
SAGA Diagnostics
Biocartis
Lucence Health Inc
F. Hoffmann-La Roche AG
Myriad Genetics Inc
MDx Health
QIAGEN
Biocept Inc
Illumina Inc
The Menarini Group

In Chapter 5 and Chapter 7.3, based on types, the Liquid Biopsy in Cancer Diagnostics market from 2017 to 2027 is primarily split into:

Instruments
Reagents & Kits

In Chapter 6 and Chapter 7.4, based on applications, the Liquid Biopsy in Cancer Diagnostics market from 2017 to 2027 covers:

Lung Cancer
Breast Cancer
Colon Cancer
Others

Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historical data and forecast (2017-2027) of the following regions are covered in Chapter 4 and Chapter 7:

United States

Europe

China

Japan

India

Southeast Asia

Latin America

Middle East and Africa

Client Focus

1. Does this report consider the impact of COVID-19 and the Russia-Ukraine war on the Liquid Biopsy in Cancer Diagnostics market?

Yes. As the COVID-19 and the Russia-Ukraine war are profoundly affecting the global supply chain relationship and raw material price system, we have definitely taken them into consideration throughout the research, and in Chapters 1.7, 2.7, 4.X.1, 7.5, 8.7, we elaborate at full length on the impact of the pandemic and the war on the Liquid Biopsy in Cancer Diagnostics Industry.

2. How do you determine the list of the key players included in the report?

With the aim of clearly revealing the competitive situation of the industry, we concretely analyze not only the leading enterprises that have a voice on a global scale, but also the regional small and medium-sized companies that play key roles and have plenty of potential growth.

Please find the key player list in Summary.

3. What are your main data sources?

Both Primary and Secondary data sources are being used while compiling the report.

Primary sources include extensive interviews of key opinion leaders and industry experts (such as experienced front-line staff, directors, CEOs, and marketing executives), downstream distributors, as well as end-users.

Secondary sources include the research of the annual and financial reports of the top companies, public files, new journals, etc. We also cooperate with some third-party databases.

Please find a more complete list of data sources in Chapters 11.2.1 & 11.2.2.

4. Can I modify the scope of the report and customize it to suit my requirements?

Yes. Customized requirements of multi-dimensional, deep-level and high-quality can help our customers precisely grasp market opportunities, effortlessly confront market challenges, properly formulate market strategies and act promptly, thus to win them sufficient time and space for market competition.

Outline

Chapter 1 mainly defines the market scope and introduces the macro overview of the industry, with an executive summary of different market segments ((by type, application, region, etc.), including the definition, market size, and trend of each market segment.

Chapter 2 provides a qualitative analysis of the current status and future trends of the market. Industry Entry Barriers, market drivers, market challenges, emerging markets, consumer preference analysis, together with the impact of the COVID-19 outbreak will all be thoroughly explained.

Chapter 3 analyzes the current competitive situation of the market by providing data regarding the players, including their sales volume and revenue with corresponding market shares, price and gross margin. In addition, information about market concentration ratio, mergers, acquisitions, and expansion plans will also be covered.

Chapter 4 focuses on the regional market, presenting detailed data (i.e., sales volume, revenue, price, gross margin) of the most representative regions and countries in the world.

Chapter 5 provides the analysis of various market segments according to product types, covering sales volume, revenue along with market share and growth rate, plus the price analysis of each type.

Chapter 6 shows the breakdown data of different applications, including the consumption and revenue with market share and growth rate, with the aim of helping the readers to take a close-up look at the downstream market.

Chapter 7 provides a combination of quantitative and qualitative analyses of the market size and development trends in the next five years. The forecast information of the whole, as well as the breakdown market, offers the readers a chance to look into the future of the industry.

Chapter 8 is the analysis of the whole market industrial chain, covering key raw materials suppliers and price analysis, manufacturing cost structure analysis, alternative product analysis, also providing information on major distributors, downstream buyers, and the impact of COVID-19 pandemic.

Chapter 9 shares a list of the key players in the market, together with their basic information, product profiles, market performance (i.e., sales volume, price, revenue, gross margin), recent development, SWOT analysis, etc.

Chapter 10 is the conclusion of the report which helps the readers to sum up the main findings and points.

Chapter 11 introduces the market research methods and data sources.

Years considered for this report:

Historical Years: 2017-2021

Base Year: 2021

Estimated Year: 2022

Forecast Period: 2022-2027

1 LIQUID BIOPSY IN CANCER DIAGNOSTICS MARKET OVERVIEW

1.1 Product Overview and Scope of Liquid Biopsy in Cancer Diagnostics Market
1.2 Liquid Biopsy in Cancer Diagnostics Market Segment by Type
  1.2.1 Global Liquid Biopsy in Cancer Diagnostics Market Sales Volume and CAGR (%) Comparison by Type (2017-2027)
1.3 Global Liquid Biopsy in Cancer Diagnostics Market Segment by Application
  1.3.1 Liquid Biopsy in Cancer Diagnostics Market Consumption (Sales Volume) Comparison by Application (2017-2027)
1.4 Global Liquid Biopsy in Cancer Diagnostics Market, Region Wise (2017-2027)
  1.4.1 Global Liquid Biopsy in Cancer Diagnostics Market Size (Revenue) and CAGR (%) Comparison by Region (2017-2027)
  1.4.2 United States Liquid Biopsy in Cancer Diagnostics Market Status and Prospect (2017-2027)
  1.4.3 Europe Liquid Biopsy in Cancer Diagnostics Market Status and Prospect (2017-2027)
  1.4.4 China Liquid Biopsy in Cancer Diagnostics Market Status and Prospect (2017-2027)
  1.4.5 Japan Liquid Biopsy in Cancer Diagnostics Market Status and Prospect (2017-2027)
  1.4.6 India Liquid Biopsy in Cancer Diagnostics Market Status and Prospect (2017-2027)
  1.4.7 Southeast Asia Liquid Biopsy in Cancer Diagnostics Market Status and Prospect (2017-2027)
  1.4.8 Latin America Liquid Biopsy in Cancer Diagnostics Market Status and Prospect (2017-2027)
  1.4.9 Middle East and Africa Liquid Biopsy in Cancer Diagnostics Market Status and Prospect (2017-2027)
1.5 Global Market Size of Liquid Biopsy in Cancer Diagnostics (2017-2027)
  1.5.1 Global Liquid Biopsy in Cancer Diagnostics Market Revenue Status and Outlook (2017-2027)
  1.5.2 Global Liquid Biopsy in Cancer Diagnostics Market Sales Volume Status and Outlook (2017-2027)
1.6 Global Macroeconomic Analysis
1.7 The impact of the Russia-Ukraine war on the Liquid Biopsy in Cancer Diagnostics Market

2 INDUSTRY OUTLOOK

2.1 Liquid Biopsy in Cancer Diagnostics Industry Technology Status and Trends
2.2 Industry Entry Barriers
  2.2.1 Analysis of Financial Barriers
  2.2.2 Analysis of Technical Barriers
  2.2.3 Analysis of Talent Barriers
  2.2.4 Analysis of Brand Barrier
2.3 Liquid Biopsy in Cancer Diagnostics Market Drivers Analysis
2.4 Liquid Biopsy in Cancer Diagnostics Market Challenges Analysis
2.5 Emerging Market Trends
2.6 Consumer Preference Analysis
2.7 Liquid Biopsy in Cancer Diagnostics Industry Development Trends under COVID-19 Outbreak
  2.7.1 Global COVID-19 Status Overview
  2.7.2 Influence of COVID-19 Outbreak on Liquid Biopsy in Cancer Diagnostics Industry Development

3 GLOBAL LIQUID BIOPSY IN CANCER DIAGNOSTICS MARKET LANDSCAPE BY PLAYER

3.1 Global Liquid Biopsy in Cancer Diagnostics Sales Volume and Share by Player (2017-2022)
3.2 Global Liquid Biopsy in Cancer Diagnostics Revenue and Market Share by Player (2017-2022)
3.3 Global Liquid Biopsy in Cancer Diagnostics Average Price by Player (2017-2022)
3.4 Global Liquid Biopsy in Cancer Diagnostics Gross Margin by Player (2017-2022)
3.5 Liquid Biopsy in Cancer Diagnostics Market Competitive Situation and Trends
  3.5.1 Liquid Biopsy in Cancer Diagnostics Market Concentration Rate
  3.5.2 Liquid Biopsy in Cancer Diagnostics Market Share of Top 3 and Top 6 Players
  3.5.3 Mergers & Acquisitions, Expansion

4 GLOBAL LIQUID BIOPSY IN CANCER DIAGNOSTICS SALES VOLUME AND REVENUE REGION WISE (2017-2022)

4.1 Global Liquid Biopsy in Cancer Diagnostics Sales Volume and Market Share, Region Wise (2017-2022)
4.2 Global Liquid Biopsy in Cancer Diagnostics Revenue and Market Share, Region Wise (2017-2022)
4.3 Global Liquid Biopsy in Cancer Diagnostics Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.4 United States Liquid Biopsy in Cancer Diagnostics Sales Volume, Revenue, Price and Gross Margin (2017-2022)
  4.4.1 United States Liquid Biopsy in Cancer Diagnostics Market Under COVID-19
4.5 Europe Liquid Biopsy in Cancer Diagnostics Sales Volume, Revenue, Price and Gross Margin (2017-2022)
  4.5.1 Europe Liquid Biopsy in Cancer Diagnostics Market Under COVID-19
4.6 China Liquid Biopsy in Cancer Diagnostics Sales Volume, Revenue, Price and Gross Margin (2017-2022)
  4.6.1 China Liquid Biopsy in Cancer Diagnostics Market Under COVID-19
4.7 Japan Liquid Biopsy in Cancer Diagnostics Sales Volume, Revenue, Price and Gross Margin (2017-2022)
  4.7.1 Japan Liquid Biopsy in Cancer Diagnostics Market Under COVID-19
4.8 India Liquid Biopsy in Cancer Diagnostics Sales Volume, Revenue, Price and Gross Margin (2017-2022)
  4.8.1 India Liquid Biopsy in Cancer Diagnostics Market Under COVID-19
4.9 Southeast Asia Liquid Biopsy in Cancer Diagnostics Sales Volume, Revenue, Price and Gross Margin (2017-2022)
  4.9.1 Southeast Asia Liquid Biopsy in Cancer Diagnostics Market Under COVID-19
4.10 Latin America Liquid Biopsy in Cancer Diagnostics Sales Volume, Revenue, Price and Gross Margin (2017-2022)
  4.10.1 Latin America Liquid Biopsy in Cancer Diagnostics Market Under COVID-19
4.11 Middle East and Africa Liquid Biopsy in Cancer Diagnostics Sales Volume, Revenue, Price and Gross Margin (2017-2022)
  4.11.1 Middle East and Africa Liquid Biopsy in Cancer Diagnostics Market Under COVID-19

5 GLOBAL LIQUID BIOPSY IN CANCER DIAGNOSTICS SALES VOLUME, REVENUE, PRICE TREND BY TYPE

5.1 Global Liquid Biopsy in Cancer Diagnostics Sales Volume and Market Share by Type (2017-2022)
5.2 Global Liquid Biopsy in Cancer Diagnostics Revenue and Market Share by Type (2017-2022)
5.3 Global Liquid Biopsy in Cancer Diagnostics Price by Type (2017-2022)
5.4 Global Liquid Biopsy in Cancer Diagnostics Sales Volume, Revenue and Growth Rate by Type (2017-2022)
  5.4.1 Global Liquid Biopsy in Cancer Diagnostics Sales Volume, Revenue and Growth Rate of Instruments (2017-2022)
  5.4.2 Global Liquid Biopsy in Cancer Diagnostics Sales Volume, Revenue and Growth Rate of Reagents & Kits (2017-2022)

6 GLOBAL LIQUID BIOPSY IN CANCER DIAGNOSTICS MARKET ANALYSIS BY APPLICATION

6.1 Global Liquid Biopsy in Cancer Diagnostics Consumption and Market Share by Application (2017-2022)
6.2 Global Liquid Biopsy in Cancer Diagnostics Consumption Revenue and Market Share by Application (2017-2022)
6.3 Global Liquid Biopsy in Cancer Diagnostics Consumption and Growth Rate by Application (2017-2022)
  6.3.1 Global Liquid Biopsy in Cancer Diagnostics Consumption and Growth Rate of Lung Cancer (2017-2022)
  6.3.2 Global Liquid Biopsy in Cancer Diagnostics Consumption and Growth Rate of Breast Cancer (2017-2022)
  6.3.3 Global Liquid Biopsy in Cancer Diagnostics Consumption and Growth Rate of Colon Cancer (2017-2022)
  6.3.4 Global Liquid Biopsy in Cancer Diagnostics Consumption and Growth Rate of Others (2017-2022)

7 GLOBAL LIQUID BIOPSY IN CANCER DIAGNOSTICS MARKET FORECAST (2022-2027)

7.1 Global Liquid Biopsy in Cancer Diagnostics Sales Volume, Revenue Forecast (2022-2027)
  7.1.1 Global Liquid Biopsy in Cancer Diagnostics Sales Volume and Growth Rate Forecast (2022-2027)
  7.1.2 Global Liquid Biopsy in Cancer Diagnostics Revenue and Growth Rate Forecast (2022-2027)
  7.1.3 Global Liquid Biopsy in Cancer Diagnostics Price and Trend Forecast (2022-2027)
7.2 Global Liquid Biopsy in Cancer Diagnostics Sales Volume and Revenue Forecast, Region Wise (2022-2027)
  7.2.1 United States Liquid Biopsy in Cancer Diagnostics Sales Volume and Revenue Forecast (2022-2027)
  7.2.2 Europe Liquid Biopsy in Cancer Diagnostics Sales Volume and Revenue Forecast (2022-2027)
  7.2.3 China Liquid Biopsy in Cancer Diagnostics Sales Volume and Revenue Forecast (2022-2027)
  7.2.4 Japan Liquid Biopsy in Cancer Diagnostics Sales Volume and Revenue Forecast (2022-2027)
  7.2.5 India Liquid Biopsy in Cancer Diagnostics Sales Volume and Revenue Forecast (2022-2027)
  7.2.6 Southeast Asia Liquid Biopsy in Cancer Diagnostics Sales Volume and Revenue Forecast (2022-2027)
  7.2.7 Latin America Liquid Biopsy in Cancer Diagnostics Sales Volume and Revenue Forecast (2022-2027)
  7.2.8 Middle East and Africa Liquid Biopsy in Cancer Diagnostics Sales Volume and Revenue Forecast (2022-2027)
7.3 Global Liquid Biopsy in Cancer Diagnostics Sales Volume, Revenue and Price Forecast by Type (2022-2027)
  7.3.1 Global Liquid Biopsy in Cancer Diagnostics Revenue and Growth Rate of Instruments (2022-2027)
  7.3.2 Global Liquid Biopsy in Cancer Diagnostics Revenue and Growth Rate of Reagents & Kits (2022-2027)
7.4 Global Liquid Biopsy in Cancer Diagnostics Consumption Forecast by Application (2022-2027)
  7.4.1 Global Liquid Biopsy in Cancer Diagnostics Consumption Value and Growth Rate of Lung Cancer(2022-2027)
  7.4.2 Global Liquid Biopsy in Cancer Diagnostics Consumption Value and Growth Rate of Breast Cancer(2022-2027)
  7.4.3 Global Liquid Biopsy in Cancer Diagnostics Consumption Value and Growth Rate of Colon Cancer(2022-2027)
  7.4.4 Global Liquid Biopsy in Cancer Diagnostics Consumption Value and Growth Rate of Others(2022-2027)
7.5 Liquid Biopsy in Cancer Diagnostics Market Forecast Under COVID-19

8 LIQUID BIOPSY IN CANCER DIAGNOSTICS MARKET UPSTREAM AND DOWNSTREAM ANALYSIS

8.1 Liquid Biopsy in Cancer Diagnostics Industrial Chain Analysis
8.2 Key Raw Materials Suppliers and Price Analysis
8.3 Manufacturing Cost Structure Analysis
  8.3.1 Labor Cost Analysis
  8.3.2 Energy Costs Analysis
  8.3.3 R&D Costs Analysis
8.4 Alternative Product Analysis
8.5 Major Distributors of Liquid Biopsy in Cancer Diagnostics Analysis
8.6 Major Downstream Buyers of Liquid Biopsy in Cancer Diagnostics Analysis
8.7 Impact of COVID-19 and the Russia-Ukraine war on the Upstream and Downstream in the Liquid Biopsy in Cancer Diagnostics Industry

9 PLAYERS PROFILES

9.1 Bio-Techne
  9.1.1 Bio-Techne Basic Information, Manufacturing Base, Sales Region and Competitors
  9.1.2 Liquid Biopsy in Cancer Diagnostics Product Profiles, Application and Specification
  9.1.3 Bio-Techne Market Performance (2017-2022)
  9.1.4 Recent Development
  9.1.5 SWOT Analysis
9.2 Neogenomics Laboratories
  9.2.1 Neogenomics Laboratories Basic Information, Manufacturing Base, Sales Region and Competitors
  9.2.2 Liquid Biopsy in Cancer Diagnostics Product Profiles, Application and Specification
  9.2.3 Neogenomics Laboratories Market Performance (2017-2022)
  9.2.4 Recent Development
  9.2.5 SWOT Analysis
9.3 Agilent Technologies Inc
  9.3.1 Agilent Technologies Inc Basic Information, Manufacturing Base, Sales Region and Competitors
  9.3.2 Liquid Biopsy in Cancer Diagnostics Product Profiles, Application and Specification
  9.3.3 Agilent Technologies Inc Market Performance (2017-2022)
  9.3.4 Recent Development
  9.3.5 SWOT Analysis
9.4 Personal Gemone Diagnostics Inc
  9.4.1 Personal Gemone Diagnostics Inc Basic Information, Manufacturing Base, Sales Region and Competitors
  9.4.2 Liquid Biopsy in Cancer Diagnostics Product Profiles, Application and Specification
  9.4.3 Personal Gemone Diagnostics Inc Market Performance (2017-2022)
  9.4.4 Recent Development
  9.4.5 SWOT Analysis
9.5 Guardant Health
  9.5.1 Guardant Health Basic Information, Manufacturing Base, Sales Region and Competitors
  9.5.2 Liquid Biopsy in Cancer Diagnostics Product Profiles, Application and Specification
  9.5.3 Guardant Health Market Performance (2017-2022)
  9.5.4 Recent Development
  9.5.5 SWOT Analysis
9.6 Agena Bioscience Inc
  9.6.1 Agena Bioscience Inc Basic Information, Manufacturing Base, Sales Region and Competitors
  9.6.2 Liquid Biopsy in Cancer Diagnostics Product Profiles, Application and Specification
  9.6.3 Agena Bioscience Inc Market Performance (2017-2022)
  9.6.4 Recent Development
  9.6.5 SWOT Analysis
9.7 Sysmex Corporation
  9.7.1 Sysmex Corporation Basic Information, Manufacturing Base, Sales Region and Competitors
  9.7.2 Liquid Biopsy in Cancer Diagnostics Product Profiles, Application and Specification
  9.7.3 Sysmex Corporation Market Performance (2017-2022)
  9.7.4 Recent Development
  9.7.5 SWOT Analysis
9.8 Thermo Fisher Scientific Inc
  9.8.1 Thermo Fisher Scientific Inc Basic Information, Manufacturing Base, Sales Region and Competitors
  9.8.2 Liquid Biopsy in Cancer Diagnostics Product Profiles, Application and Specification
  9.8.3 Thermo Fisher Scientific Inc Market Performance (2017-2022)
  9.8.4 Recent Development
  9.8.5 SWOT Analysis
9.9 Exact Sciences Corporation
  9.9.1 Exact Sciences Corporation Basic Information, Manufacturing Base, Sales Region and Competitors
  9.9.2 Liquid Biopsy in Cancer Diagnostics Product Profiles, Application and Specification
  9.9.3 Exact Sciences Corporation Market Performance (2017-2022)
  9.9.4 Recent Development
  9.9.5 SWOT Analysis
9.10 SAGA Diagnostics
  9.10.1 SAGA Diagnostics Basic Information, Manufacturing Base, Sales Region and Competitors
  9.10.2 Liquid Biopsy in Cancer Diagnostics Product Profiles, Application and Specification
  9.10.3 SAGA Diagnostics Market Performance (2017-2022)
  9.10.4 Recent Development
  9.10.5 SWOT Analysis
9.11 Biocartis
  9.11.1 Biocartis Basic Information, Manufacturing Base, Sales Region and Competitors
  9.11.2 Liquid Biopsy in Cancer Diagnostics Product Profiles, Application and Specification
  9.11.3 Biocartis Market Performance (2017-2022)
  9.11.4 Recent Development
  9.11.5 SWOT Analysis
9.12 Lucence Health Inc
  9.12.1 Lucence Health Inc Basic Information, Manufacturing Base, Sales Region and Competitors
  9.12.2 Liquid Biopsy in Cancer Diagnostics Product Profiles, Application and Specification
  9.12.3 Lucence Health Inc Market Performance (2017-2022)
  9.12.4 Recent Development
  9.12.5 SWOT Analysis
9.13 F. Hoffmann-La Roche AG
  9.13.1 F. Hoffmann-La Roche AG Basic Information, Manufacturing Base, Sales Region and Competitors
  9.13.2 Liquid Biopsy in Cancer Diagnostics Product Profiles, Application and Specification
  9.13.3 F. Hoffmann-La Roche AG Market Performance (2017-2022)
  9.13.4 Recent Development
  9.13.5 SWOT Analysis
9.14 Myriad Genetics Inc
  9.14.1 Myriad Genetics Inc Basic Information, Manufacturing Base, Sales Region and Competitors
  9.14.2 Liquid Biopsy in Cancer Diagnostics Product Profiles, Application and Specification
  9.14.3 Myriad Genetics Inc Market Performance (2017-2022)
  9.14.4 Recent Development
  9.14.5 SWOT Analysis
9.15 MDx Health
  9.15.1 MDx Health Basic Information, Manufacturing Base, Sales Region and Competitors
  9.15.2 Liquid Biopsy in Cancer Diagnostics Product Profiles, Application and Specification
  9.15.3 MDx Health Market Performance (2017-2022)
  9.15.4 Recent Development
  9.15.5 SWOT Analysis
9.16 QIAGEN
  9.16.1 QIAGEN Basic Information, Manufacturing Base, Sales Region and Competitors
  9.16.2 Liquid Biopsy in Cancer Diagnostics Product Profiles, Application and Specification
  9.16.3 QIAGEN Market Performance (2017-2022)
  9.16.4 Recent Development
  9.16.5 SWOT Analysis
9.17 Biocept Inc
  9.17.1 Biocept Inc Basic Information, Manufacturing Base, Sales Region and Competitors
  9.17.2 Liquid Biopsy in Cancer Diagnostics Product Profiles, Application and Specification
  9.17.3 Biocept Inc Market Performance (2017-2022)
  9.17.4 Recent Development
  9.17.5 SWOT Analysis
9.18 Illumina Inc
  9.18.1 Illumina Inc Basic Information, Manufacturing Base, Sales Region and Competitors
  9.18.2 Liquid Biopsy in Cancer Diagnostics Product Profiles, Application and Specification
  9.18.3 Illumina Inc Market Performance (2017-2022)
  9.18.4 Recent Development
  9.18.5 SWOT Analysis
9.19 The Menarini Group
  9.19.1 The Menarini Group Basic Information, Manufacturing Base, Sales Region and Competitors
  9.19.2 Liquid Biopsy in Cancer Diagnostics Product Profiles, Application and Specification
  9.19.3 The Menarini Group Market Performance (2017-2022)
  9.19.4 Recent Development
  9.19.5 SWOT Analysis

10 RESEARCH FINDINGS AND CONCLUSION


11 APPENDIX

11.1 Methodology
11.2 Research Data Source

LIST OF TABLES AND FIGURES




Figure Liquid Biopsy in Cancer Diagnostics Product Picture

Table Global Liquid Biopsy in Cancer Diagnostics Market Sales Volume and CAGR (%) Comparison by Type

Table Liquid Biopsy in Cancer Diagnostics Market Consumption (Sales Volume) Comparison by Application (2017-2027)

Figure Global Liquid Biopsy in Cancer Diagnostics Market Size (Revenue, Million USD) and CAGR (%) (2017-2027)

Figure United States Liquid Biopsy in Cancer Diagnostics Market Revenue (Million USD) and Growth Rate (2017-2027)

Figure Europe Liquid Biopsy in Cancer Diagnostics Market Revenue (Million USD) and Growth Rate (2017-2027)

Figure China Liquid Biopsy in Cancer Diagnostics Market Revenue (Million USD) and Growth Rate (2017-2027)

Figure Japan Liquid Biopsy in Cancer Diagnostics Market Revenue (Million USD) and Growth Rate (2017-2027)

Figure India Liquid Biopsy in Cancer Diagnostics Market Revenue (Million USD) and Growth Rate (2017-2027)

Figure Southeast Asia Liquid Biopsy in Cancer Diagnostics Market Revenue (Million USD) and Growth Rate (2017-2027)

Figure Latin America Liquid Biopsy in Cancer Diagnostics Market Revenue (Million USD) and Growth Rate (2017-2027)

Figure Middle East and Africa Liquid Biopsy in Cancer Diagnostics Market Revenue (Million USD) and Growth Rate (2017-2027)

Figure Global Liquid Biopsy in Cancer Diagnostics Market Sales Volume Status and Outlook (2017-2027)

Table Global Macroeconomic Analysis

Figure Global COVID-19 Status Overview

Table Influence of COVID-19 Outbreak on Liquid Biopsy in Cancer Diagnostics Industry Development

Table Global Liquid Biopsy in Cancer Diagnostics Sales Volume by Player (2017-2022)

Table Global Liquid Biopsy in Cancer Diagnostics Sales Volume Share by Player (2017-2022)

Figure Global Liquid Biopsy in Cancer Diagnostics Sales Volume Share by Player in 2021

Table Liquid Biopsy in Cancer Diagnostics Revenue (Million USD) by Player (2017-2022)

Table Liquid Biopsy in Cancer Diagnostics Revenue Market Share by Player (2017-2022)

Table Liquid Biopsy in Cancer Diagnostics Price by Player (2017-2022)

Table Liquid Biopsy in Cancer Diagnostics Gross Margin by Player (2017-2022)

Table Mergers & Acquisitions, Expansion Plans

Table Global Liquid Biopsy in Cancer Diagnostics Sales Volume, Region Wise (2017-2022)

Table Global Liquid Biopsy in Cancer Diagnostics Sales Volume Market Share, Region Wise (2017-2022)

Figure Global Liquid Biopsy in Cancer Diagnostics Sales Volume Market Share, Region Wise (2017-2022)

Figure Global Liquid Biopsy in Cancer Diagnostics Sales Volume Market Share, Region Wise in 2021

Table Global Liquid Biopsy in Cancer Diagnostics Revenue (Million USD), Region Wise (2017-2022)

Table Global Liquid Biopsy in Cancer Diagnostics Revenue Market Share, Region Wise (2017-2022)

Figure Global Liquid Biopsy in Cancer Diagnostics Revenue Market Share, Region Wise (2017-2022)

Figure Global Liquid Biopsy in Cancer Diagnostics Revenue Market Share, Region Wise in 2021

Table Global Liquid Biopsy in Cancer Diagnostics Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)

Table United States Liquid Biopsy in Cancer Diagnostics Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)

Table Europe Liquid Biopsy in Cancer Diagnostics Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)

Table China Liquid Biopsy in Cancer Diagnostics Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)

Table Japan Liquid Biopsy in Cancer Diagnostics Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)

Table India Liquid Biopsy in Cancer Diagnostics Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)

Table Southeast Asia Liquid Biopsy in Cancer Diagnostics Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)

Table Latin America Liquid Biopsy in Cancer Diagnostics Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)

Table Middle East and Africa Liquid Biopsy in Cancer Diagnostics Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)

Table Global Liquid Biopsy in Cancer Diagnostics Sales Volume by Type (2017-2022)

Table Global Liquid Biopsy in Cancer Diagnostics Sales Volume Market Share by Type (2017-2022)

Figure Global Liquid Biopsy in Cancer Diagnostics Sales Volume Market Share by Type in 2021

Table Global Liquid Biopsy in Cancer Diagnostics Revenue (Million USD) by Type (2017-2022)

Table Global Liquid Biopsy in Cancer Diagnostics Revenue Market Share by Type (2017-2022)

Figure Global Liquid Biopsy in Cancer Diagnostics Revenue Market Share by Type in 2021

Table Liquid Biopsy in Cancer Diagnostics Price by Type (2017-2022)

Figure Global Liquid Biopsy in Cancer Diagnostics Sales Volume and Growth Rate of Instruments (2017-2022)
Figure Global Liquid Biopsy in Cancer Diagnostics Revenue (Million USD) and Growth Rate of Instruments (2017-2022)
Figure Global Liquid Biopsy in Cancer Diagnostics Sales Volume and Growth Rate of Reagents & Kits (2017-2022)
Figure Global Liquid Biopsy in Cancer Diagnostics Revenue (Million USD) and Growth Rate of Reagents & Kits (2017-2022)
Table Global Liquid Biopsy in Cancer Diagnostics Consumption by Application (2017-2022)

Table Global Liquid Biopsy in Cancer Diagnostics Consumption Market Share by Application (2017-2022)

Table Global Liquid Biopsy in Cancer Diagnostics Consumption Revenue (Million USD) by Application (2017-2022)

Table Global Liquid Biopsy in Cancer Diagnostics Consumption Revenue Market Share by Application (2017-2022)

Table Global Liquid Biopsy in Cancer Diagnostics Consumption and Growth Rate of Lung Cancer (2017-2022)
Table Global Liquid Biopsy in Cancer Diagnostics Consumption and Growth Rate of Breast Cancer (2017-2022)
Table Global Liquid Biopsy in Cancer Diagnostics Consumption and Growth Rate of Colon Cancer (2017-2022)
Table Global Liquid Biopsy in Cancer Diagnostics Consumption and Growth Rate of Others (2017-2022)
Figure Global Liquid Biopsy in Cancer Diagnostics Sales Volume and Growth Rate Forecast (2022-2027)

Figure Global Liquid Biopsy in Cancer Diagnostics Revenue (Million USD) and Growth Rate Forecast (2022-2027)

Figure Global Liquid Biopsy in Cancer Diagnostics Price and Trend Forecast (2022-2027)

Figure USA Liquid Biopsy in Cancer Diagnostics Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)

Figure USA Liquid Biopsy in Cancer Diagnostics Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)

Figure Europe Liquid Biopsy in Cancer Diagnostics Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)

Figure Europe Liquid Biopsy in Cancer Diagnostics Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)

Figure China Liquid Biopsy in Cancer Diagnostics Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)

Figure China Liquid Biopsy in Cancer Diagnostics Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)

Figure Japan Liquid Biopsy in Cancer Diagnostics Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)

Figure Japan Liquid Biopsy in Cancer Diagnostics Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)

Figure India Liquid Biopsy in Cancer Diagnostics Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)

Figure India Liquid Biopsy in Cancer Diagnostics Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)

Figure Southeast Asia Liquid Biopsy in Cancer Diagnostics Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)

Figure Southeast Asia Liquid Biopsy in Cancer Diagnostics Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)

Figure Latin America Liquid Biopsy in Cancer Diagnostics Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)

Figure Latin America Liquid Biopsy in Cancer Diagnostics Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)

Figure Middle East and Africa Liquid Biopsy in Cancer Diagnostics Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)

Figure Middle East and Africa Liquid Biopsy in Cancer Diagnostics Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)

Table Global Liquid Biopsy in Cancer Diagnostics Market Sales Volume Forecast, by Type

Table Global Liquid Biopsy in Cancer Diagnostics Sales Volume Market Share Forecast, by Type

Table Global Liquid Biopsy in Cancer Diagnostics Market Revenue (Million USD) Forecast, by Type

Table Global Liquid Biopsy in Cancer Diagnostics Revenue Market Share Forecast, by Type

Table Global Liquid Biopsy in Cancer Diagnostics Price Forecast, by Type

Figure Global Liquid Biopsy in Cancer Diagnostics Revenue (Million USD) and Growth Rate of Instruments (2022-2027)
Figure Global Liquid Biopsy in Cancer Diagnostics Revenue (Million USD) and Growth Rate of Instruments (2022-2027)
Figure Global Liquid Biopsy in Cancer Diagnostics Revenue (Million USD) and Growth Rate of Reagents & Kits (2022-2027)
Figure Global Liquid Biopsy in Cancer Diagnostics Revenue (Million USD) and Growth Rate of Reagents & Kits (2022-2027)
Table Global Liquid Biopsy in Cancer Diagnostics Market Consumption Forecast, by Application

Table Global Liquid Biopsy in Cancer Diagnostics Consumption Market Share Forecast, by Application

Table Global Liquid Biopsy in Cancer Diagnostics Market Revenue (Million USD) Forecast, by Application

Table Global Liquid Biopsy in Cancer Diagnostics Revenue Market Share Forecast, by Application

Figure Global Liquid Biopsy in Cancer Diagnostics Consumption Value (Million USD) and Growth Rate of Lung Cancer (2022-2027)
Figure Global Liquid Biopsy in Cancer Diagnostics Consumption Value (Million USD) and Growth Rate of Breast Cancer (2022-2027)
Figure Global Liquid Biopsy in Cancer Diagnostics Consumption Value (Million USD) and Growth Rate of Colon Cancer (2022-2027)
Figure Global Liquid Biopsy in Cancer Diagnostics Consumption Value (Million USD) and Growth Rate of Others (2022-2027)
Figure Liquid Biopsy in Cancer Diagnostics Industrial Chain Analysis

Table Key Raw Materials Suppliers and Price Analysis

Figure Manufacturing Cost Structure Analysis

Table Alternative Product Analysis

Table Downstream Distributors

Table Downstream Buyers

Table Bio-Techne Profile
Table Bio-Techne Liquid Biopsy in Cancer Diagnostics Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Bio-Techne Liquid Biopsy in Cancer Diagnostics Sales Volume and Growth Rate
Figure Bio-Techne Revenue (Million USD) Market Share 2017-2022
Table Neogenomics Laboratories Profile
Table Neogenomics Laboratories Liquid Biopsy in Cancer Diagnostics Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Neogenomics Laboratories Liquid Biopsy in Cancer Diagnostics Sales Volume and Growth Rate
Figure Neogenomics Laboratories Revenue (Million USD) Market Share 2017-2022
Table Agilent Technologies Inc Profile
Table Agilent Technologies Inc Liquid Biopsy in Cancer Diagnostics Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Agilent Technologies Inc Liquid Biopsy in Cancer Diagnostics Sales Volume and Growth Rate
Figure Agilent Technologies Inc Revenue (Million USD) Market Share 2017-2022
Table Personal Gemone Diagnostics Inc Profile
Table Personal Gemone Diagnostics Inc Liquid Biopsy in Cancer Diagnostics Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Personal Gemone Diagnostics Inc Liquid Biopsy in Cancer Diagnostics Sales Volume and Growth Rate
Figure Personal Gemone Diagnostics Inc Revenue (Million USD) Market Share 2017-2022
Table Guardant Health Profile
Table Guardant Health Liquid Biopsy in Cancer Diagnostics Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Guardant Health Liquid Biopsy in Cancer Diagnostics Sales Volume and Growth Rate
Figure Guardant Health Revenue (Million USD) Market Share 2017-2022
Table Agena Bioscience Inc Profile
Table Agena Bioscience Inc Liquid Biopsy in Cancer Diagnostics Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Agena Bioscience Inc Liquid Biopsy in Cancer Diagnostics Sales Volume and Growth Rate
Figure Agena Bioscience Inc Revenue (Million USD) Market Share 2017-2022
Table Sysmex Corporation Profile
Table Sysmex Corporation Liquid Biopsy in Cancer Diagnostics Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Sysmex Corporation Liquid Biopsy in Cancer Diagnostics Sales Volume and Growth Rate
Figure Sysmex Corporation Revenue (Million USD) Market Share 2017-2022
Table Thermo Fisher Scientific Inc Profile
Table Thermo Fisher Scientific Inc Liquid Biopsy in Cancer Diagnostics Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Thermo Fisher Scientific Inc Liquid Biopsy in Cancer Diagnostics Sales Volume and Growth Rate
Figure Thermo Fisher Scientific Inc Revenue (Million USD) Market Share 2017-2022
Table Exact Sciences Corporation Profile
Table Exact Sciences Corporation Liquid Biopsy in Cancer Diagnostics Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Exact Sciences Corporation Liquid Biopsy in Cancer Diagnostics Sales Volume and Growth Rate
Figure Exact Sciences Corporation Revenue (Million USD) Market Share 2017-2022
Table SAGA Diagnostics Profile
Table SAGA Diagnostics Liquid Biopsy in Cancer Diagnostics Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure SAGA Diagnostics Liquid Biopsy in Cancer Diagnostics Sales Volume and Growth Rate
Figure SAGA Diagnostics Revenue (Million USD) Market Share 2017-2022
Table Biocartis Profile
Table Biocartis Liquid Biopsy in Cancer Diagnostics Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Biocartis Liquid Biopsy in Cancer Diagnostics Sales Volume and Growth Rate
Figure Biocartis Revenue (Million USD) Market Share 2017-2022
Table Lucence Health Inc Profile
Table Lucence Health Inc Liquid Biopsy in Cancer Diagnostics Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Lucence Health Inc Liquid Biopsy in Cancer Diagnostics Sales Volume and Growth Rate
Figure Lucence Health Inc Revenue (Million USD) Market Share 2017-2022
Table F. Hoffmann-La Roche AG Profile
Table F. Hoffmann-La Roche AG Liquid Biopsy in Cancer Diagnostics Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure F. Hoffmann-La Roche AG Liquid Biopsy in Cancer Diagnostics Sales Volume and Growth Rate
Figure F. Hoffmann-La Roche AG Revenue (Million USD) Market Share 2017-2022
Table Myriad Genetics Inc Profile
Table Myriad Genetics Inc Liquid Biopsy in Cancer Diagnostics Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Myriad Genetics Inc Liquid Biopsy in Cancer Diagnostics Sales Volume and Growth Rate
Figure Myriad Genetics Inc Revenue (Million USD) Market Share 2017-2022
Table MDx Health Profile
Table MDx Health Liquid Biopsy in Cancer Diagnostics Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure MDx Health Liquid Biopsy in Cancer Diagnostics Sales Volume and Growth Rate
Figure MDx Health Revenue (Million USD) Market Share 2017-2022
Table QIAGEN Profile
Table QIAGEN Liquid Biopsy in Cancer Diagnostics Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure QIAGEN Liquid Biopsy in Cancer Diagnostics Sales Volume and Growth Rate
Figure QIAGEN Revenue (Million USD) Market Share 2017-2022
Table Biocept Inc Profile
Table Biocept Inc Liquid Biopsy in Cancer Diagnostics Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Biocept Inc Liquid Biopsy in Cancer Diagnostics Sales Volume and Growth Rate
Figure Biocept Inc Revenue (Million USD) Market Share 2017-2022
Table Illumina Inc Profile
Table Illumina Inc Liquid Biopsy in Cancer Diagnostics Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Illumina Inc Liquid Biopsy in Cancer Diagnostics Sales Volume and Growth Rate
Figure Illumina Inc Revenue (Million USD) Market Share 2017-2022
Table The Menarini Group Profile
Table The Menarini Group Liquid Biopsy in Cancer Diagnostics Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure The Menarini Group Liquid Biopsy in Cancer Diagnostics Sales Volume and Growth Rate
Figure The Menarini Group Revenue (Million USD) Market Share 2017-2022






More Publications